Kura Oncology, Inc.
KURA
$7.34
$0.050.69%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 727.40M | 455.30M | 491.52M | 527.12M | 423.96M |
Total Receivables | 6.10M | 4.70M | 4.70M | 4.30M | 1.10M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 11.33M | 3.19M | 3.55M | 6.41M | 7.42M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 744.83M | 463.19M | 499.77M | 537.84M | 432.48M |
|
|||||
Total Current Assets | 744.83M | 463.19M | 499.77M | 537.84M | 432.48M |
Net Property, Plant & Equipment | 7.49M | 7.42M | 7.92M | 8.41M | 8.85M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 7.85M | 8.23M | 7.43M | 7.67M | 7.60M |
Total Assets | 760.16M | 478.84M | 515.12M | 553.91M | 448.94M |
|
|||||
Total Accounts Payable | 1.47M | 3.01M | 2.06M | 7.53M | 2.30M |
Total Accrued Expenses | 46.42M | 33.96M | 29.07M | 23.37M | 31.46M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.49M | 3.41M | 2.31M | 1.36M | 1.51M |
Total Finance Division Other Current Liabilities | 26.33M | -- | -- | -- | -- |
Total Other Current Liabilities | 26.33M | -- | -- | -- | -- |
Total Current Liabilities | 78.71M | 40.37M | 33.45M | 32.27M | 35.26M |
|
|||||
Total Current Liabilities | 78.71M | 40.37M | 33.45M | 32.27M | 35.26M |
Long-Term Debt | 6.92M | 7.76M | 8.58M | 9.38M | 9.33M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 5.19M | 5.47M | 5.84M | 6.23M | 6.36M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 255.70M | 1.47M | 1.18M | 951.00K | 705.00K |
Total Liabilities | 346.52M | 55.07M | 49.05M | 48.82M | 51.66M |
|
|||||
Common Stock & APIC | 1.31B | 1.30B | 1.29B | 1.28B | 1.12B |
Retained Earnings | -895.42M | -876.21M | -821.80M | -770.96M | -721.44M |
Treasury Stock & Other | 764.00K | 1.12M | -463.00K | -816.00K | -1.27M |
Total Common Equity | 413.64M | 423.77M | 466.07M | 505.08M | 397.27M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 413.64M | 423.77M | 466.07M | 505.08M | 397.27M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 413.64M | 423.77M | 466.07M | 505.08M | 397.27M |
|